Electrocore (NASDAQ:ECOR) Director Carrie Smith Cox bought 7,300 shares of the business’s stock in a transaction dated Monday, December 3rd. The shares were bought at an average cost of $6.79 per share, with a total value of $49,567.00. The purchase was disclosed in a filing with the SEC, which can be accessed through this link.
Shares of ECOR stock traded down $0.03 on Thursday, reaching $6.54. 249 shares of the company were exchanged, compared to its average volume of 85,824. Electrocore has a 1 year low of $5.40 and a 1 year high of $20.25.
Electrocore (NASDAQ:ECOR) last released its earnings results on Tuesday, November 13th. The company reported ($0.45) EPS for the quarter, hitting analysts’ consensus estimates of ($0.45). The company had revenue of $0.15 million for the quarter. As a group, equities analysts anticipate that Electrocore will post -1.13 EPS for the current fiscal year.
Hedge funds have recently added to or reduced their stakes in the company. Brown Brothers Harriman & Co. purchased a new stake in Electrocore during the 3rd quarter valued at about $140,000. Point72 Asset Management L.P. purchased a new stake in Electrocore during the 2nd quarter valued at about $206,000. SCP Investment LP purchased a new stake in Electrocore during the 3rd quarter valued at about $260,000. Bfsg LLC purchased a new stake in Electrocore during the 3rd quarter valued at about $301,000. Finally, Citadel Advisors LLC purchased a new stake in Electrocore during the 2nd quarter valued at about $427,000. 16.31% of the stock is owned by institutional investors and hedge funds.
ILLEGAL ACTIVITY WARNING: “Carrie Smith Cox Acquires 7,300 Shares of Electrocore (ECOR) Stock” was posted by Dakota Financial News and is the sole property of of Dakota Financial News. If you are accessing this report on another website, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this report can be accessed at https://dakotafinancialnews.com/2018/12/06/carrie-smith-cox-acquires-7300-shares-of-electrocore-ecor-stock.html.
Electrocore Company Profile
electroCore, LLC, a bioelectronic medicine company, engages in developing a range of patient-administered non-invasive vagus nerve stimulation therapies for the treatment of various conditions in neurology, rheumatology, and other fields. It is developing gammaCore, a prescription-only vagus nerve stimulation therapy, for the acute treatment of pain associated with migraine and episodic cluster headache in adults.
Recommended Story: What is the Dividend Aristocrat Index?
Receive News & Ratings for Electrocore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Electrocore and related companies with MarketBeat.com's FREE daily email newsletter.